SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001338095-16-000132
Filing Date
2016-08-23
Accepted
2016-08-23 16:02:27
Documents
17
Period of Report
2016-08-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrx8-kjulymor_08232016.htm 8-K 37012
2 EXHIBIT 99.1 nrxjulymor.htm EX-99.1 99420
3 nrxjulymor001.jpg GRAPHIC 93867
4 nrxjulymor002.jpg GRAPHIC 25830
5 nrxjulymor003.jpg GRAPHIC 14384
6 nrxjulymor004.jpg GRAPHIC 118358
7 nrxjulymor005.jpg GRAPHIC 223933
8 nrxjulymor006.jpg GRAPHIC 143976
9 nrxjulymor007.jpg GRAPHIC 97466
10 nrxjulymor008.jpg GRAPHIC 65623
11 nrxjulymor009.jpg GRAPHIC 90664
12 nrxjulymor010.jpg GRAPHIC 145188
13 nrxjulymor011.jpg GRAPHIC 75990
14 nrxjulymor012.jpg GRAPHIC 81981
15 nrxjulymor013.jpg GRAPHIC 161789
16 nrxjulymor014.jpg GRAPHIC 99262
17 nrxjulymor015.jpg GRAPHIC 121485
  Complete submission text file 0001338095-16-000132.txt   2242953
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36303 | Film No.: 161847280
SIC: 2834 Pharmaceutical Preparations